The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of 4566788112 - ICLUSIG 15 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products.
Generated 3/19/25, 9:54 AM